Earnings calendar/FHTX
Foghorn Therapeutics Inc. (FHTX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 4, 2026
Consensus estimate row
EPS target
$-0.23
Street estimate
Revenue target
$7.1M
Street estimate
Trailing EPS (avg 4Q)
$-0.24
Beat rate last 4: 50%
Latest EPS YoY
+64.3%
vs 2025-08-05
Latest revenue YoY
+113.0%
How results look so far
Trailing revenue (avg 4Q)
$9.2M
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS beat
EPS actual / est
$-0.10 / $-0.24
+59.2%
Revenue actual / est
$16.1M / $6.8M
+136.6%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/4/2026upcoming | $-0.23 | Pending | — | $7.1M | Pending | — |
| 8/6/2026 | $-0.24 | $-0.10 | +59.2% | $6.8M | $16.1M | +136.6% |
| 5/13/2026upcoming | $-0.28 | Pending | — | $7.9M | Pending | — |
| 5/7/2026 | $-0.28 | $-0.29 | -3.6% | $7.9M | $3.3M | -58.9% |
| 3/16/2026upcoming | $-0.26 | Pending | — | $9.5M | Pending | — |
| 3/12/2026upcoming | $-0.24 | Pending | — | $9.5M | Pending | — |
| 3/11/2026 | $-0.28 | $-0.34 | -21.4% | $10.2M | $9.2M | -8.9% |
| 3/5/2026upcoming | $-0.28 | Pending | — | $9.5M | Pending | — |
| 11/5/2025 | $-0.31 | $-0.25 | +19.4% | $9.5M | $8.2M | -14.2% |
| 8/5/2025 | $-0.31 | $-0.28 | +9.7% | $8.2M | $7.6M | -7.5% |
| 5/14/2025 | $-0.30 | $-0.30 | 0.0% | $6.2M | $6.0M | -4.6% |
| 3/6/2025 | $-0.43 | $-0.30 | +30.2% | $8.7M | $2.9M | -67.1% |
| 11/4/2024 | $-0.42 | $-0.31 | +26.2% | $8.1M | $7.8M | -4.0% |
| 8/8/2024 | $-0.60 | $-0.45 | +25.0% | $6.0M | $6.9M | +14.0% |
| 5/6/2024 | $-0.55 | $-0.59 | -7.3% | $6.9M | $5.0M | -26.9% |
| 3/7/2024 | $-0.79 | $-0.57 | +27.8% | $4.6M | $5.8M | +24.9% |
| 11/2/2023 | $-0.72 | $-0.34 | +52.8% | $4.6M | $17.5M | +278.3% |
| 8/4/2023 | $-0.73 | $-0.70 | +4.1% | $6.3M | $5.6M | -10.6% |
| 5/8/2023 | $-0.68 | $-0.73 | -7.4% | $6.3M | $5.3M | -15.2% |
| 3/9/2023 | $-0.59 | $-0.69 | -16.9% | $5.0M | $4.2M | -17.0% |
| 11/8/2022 | $-0.60 | $-0.62 | -3.3% | $8.5M | $6.6M | -21.8% |
| 8/9/2022 | $-0.53 | $-0.66 | -24.5% | $9.6M | $4.5M | -53.1% |
| 5/9/2022 | $-0.40 | $-0.65 | -62.5% | $9.4M | $3.9M | -58.4% |
| 3/10/2022 | $-0.74 | $-0.77 | -4.1% | $709,750 | $713,000 | +0.5% |
| 11/9/2021 | $-0.66 | $-0.71 | -7.6% | $250,000 | $41,000 | -83.6% |
| 8/10/2021 | $-0.63 | $-0.63 | 0.0% | $279,000 | $279,000 | 0.0% |
| 5/11/2021 | $-0.63 | $-0.62 | +1.6% | $290,539 | $286,000 | -1.6% |
| 3/18/2021 | $-0.45 | $-1.86 | -313.3% | — | $251,000 | — |
| 12/4/2020 | $-1.72 | $-3.12 | -81.4% | — | $179,000 | — |
| 10/23/2020 | — | $-0.71 | — | — | Pending | — |
| 3/31/2020 | — | $-0.63 | — | — | Pending | — |
| 12/31/2019 | — | $-0.69 | — | — | Pending | — |
| 9/30/2019 | — | $-0.59 | — | — | Pending | — |
| 6/30/2019 | — | $-2.95 | — | — | Pending | — |
| 3/31/2019 | — | $-2.95 | — | — | Pending | — |
| 6/30/2018 | — | $-0.34 | — | — | Pending | — |
| 3/31/2018 | — | $-0.34 | — | — | Pending | — |
Need FHTX data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.